Search

Your search keyword '"Moliterno, David"' showing total 395 results

Search Constraints

Start Over You searched for: Author "Moliterno, David" Remove constraint Author: "Moliterno, David" Database Unpaywall Remove constraint Database: Unpaywall
395 results on '"Moliterno, David"'

Search Results

2. Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial

5. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions

6. LB-9 | Repeated Coronary Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial

7. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight

8. JACC Journals’ Pathway Forward With AI Tools

10. JACC Journals’ Pathway Forward With AI Tools

11. JACC Journals’ Pathway Forward With AI Tools

12. JACC Journals’ Pathway Forward With AI Tools

13. JACC Journals’ Pathway Forward With AI Tools

14. JACC Journals’ Pathway Forward With AI Tools

15. JACC Journals’ Pathway Forward With AI Tools

16. JACC Journals’ Pathway Forward With AI Tools

17. JACC Journals’ Pathway Forward With AI Tools

18. JACC Journals’ Pathway Forward With AI Tools

20. Biolimus-Eluting vs. Other Limus-Eluting Stents in NSTE-ACS: A Pooled Analysis of GLASSY and TWILIGHT

21. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

23. Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index

25. TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

28. Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD

30. Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study

31. Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI

33. TCT-39 Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index: TWILIGHT-BMI Analysis

34. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR

36. Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention

37. Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD

38. Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI

40. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

41. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI

49. Contributors

Catalog

Books, media, physical & digital resources